{"id":"W4401281322","doi":"10.1016/j.lungcan.2024.107919","title":"Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Pfizer (Canada); Princess Margaret Cancer Centre","funders":"National Cancer Institute; EMD Serono; International Society for Pharmacoepidemiology; Gilead Sciences; Sanofi; Genentech; AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Anaplastic lymphoma kinase; ALK inhibitor; Lung cancer; Tyrosine kinase; Tyrosine-kinase inhibitor; Cancer research; Ceritinib; Oncology; Internal medicine; Cancer; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003184271,0.0001414402,0.0004109306,0.0006908634,0.0002069828,0.0007974542,0.0003771391,0.0002965259,0.0008217604],"category_scores_gemma":[0.009666651,0.0001411536,0.0005355363,0.001374229,0.0001929102,0.0006056129,0.0003140359,0.0003930651,0.0001614851],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001022251,"about_ca_system_score_gemma":0.0007235121,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003938444,"about_ca_topic_score_gemma":0.006431518,"domain_scores_codex":[0.9975077,0.0007796012,0.0004403674,0.0005704422,0.00056308,0.0001388539],"domain_scores_gemma":[0.9837104,0.003788631,0.01093542,0.0004235521,0.0006922114,0.0004497794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004890086,0.00004629069,0.9877487,0.00006958233,0.0001701648,0.00003335287,0.00005603877,0.0006328946,0.0002554276,0.00004346067,0.0003358454,0.0101193],"study_design_scores_gemma":[0.00005005749,0.0003480765,0.9943528,0.00006904133,0.0001478412,0.0003897338,0.0001283345,0.002204856,0.0006019691,0.0001127123,0.001583416,0.0000110869],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931699,0.002267692,0.0002616287,0.0002223662,0.000008093836,0.00001533856,0.003400017,0.00000980227,0.000645204],"genre_scores_gemma":[0.9959689,0.0005344086,0.0002661218,0.00009835246,0.00001410616,0.00001793521,0.003011288,0.000003316396,0.00008561046],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003938444,"threshold_uncertainty_score":0.01684028,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01174501105919376,"score_gpt":0.329370564327469,"score_spread":0.3176255532682752,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}